Hepatitis E: Latest Developments in Knowledge

References

• WHO (2015). www.who.int
   Google Scholar
• Arankalle VA, Tsarev SA, Chadha MS et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J. Infect. Dis. 2 (171 ), 447 – 450 (1995).
   Google Scholar
• Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J. Hepatol. 48, 494 – 503 (2008).
   PubMed Web of Science ®Google Scholar
• Pérez-Gracia MT, Mateos ML, Galiana C et al. Autochthonous hepatitis E infection in a slaughterhouse worker. Am. J. Trop. Med. Hyg. 5 (77 ), 893 – 896 (2007).
   Google Scholar
• Riveiro-Barciela M, Mínguez B, Gironés R, Rodriguez-Frías F, Quer J, Buti M. Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion. J. Clin. Gastroenterol. 49 (2 ), 165 – 168 (2015).
   PubMed Web of Science ®Google Scholar
• Viswanathan R, Sidhu AS. Infectious hepatitis; clinical findings. Indian J. Med. Res. (Suppl. 45 ), 49 – 58 (1957).
   PubMedGoogle Scholar
• Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am. J. Med. 6 (68 ), 818 – 824 (1980).
   Google Scholar
• Balayan MS, Andjapardize AG, Savinskaya SS et al. Evidence for a virus in non-A, non-B hepatitis transmitted via faecal–oral route. Intervirology 20, 23 – 31 (1983).
   PubMed Web of Science ®Google Scholar
• Bradley D, Andjaparidze A, Cook EH et al. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J. Gen. Virol. 3, 731 – 738 (1988).
   Google Scholar
• Krawczynski K, Bradley DW. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J. Infect. Dis. 6 (159 ), 1042 – 1049 (1989).
   Google Scholar
• Reyes GR, Purdy MA, Kim JP et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 4948 (247 ), 1335 – 1339 (1990).
   Google Scholar
• Balayan MS, Usmanov RK, Zamyatina NA, Djumalieva DI, Karas FR. Brief report: experimental hepatitis E infection in domestic pigs. J. Med. Virol. 1 (32 ), 58 – 59 (1990).
   Google Scholar
• Schlauder GG, Dawson GJ, Erker JC et al. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J. Gen. Virol. 79 (Pt 3 ), 447 – 456 (1998).
   PubMed Web of Science ®Google Scholar
• Zaaijer HL, Yin MF, Lelie PN. Seroprevalence of hepatitis E in The Netherlands. Lancet 8820 (340 ), 681 (1992).
   Google Scholar
• Paul DA, Knigge MF, Ritter A et al. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides. J. Infect. Dis. 4 (169 ), 801 – 806 (1994).
   Google Scholar
• Buti M, Jardi R, Cotrina M et al. Hepatitis E virus infection in acute hepatitis in Spain. J. Virol. Methods. 1 (55 ), 49 – 54 (1995).
   Google Scholar
• Meng XJ, Dea S, Engle RE et al. Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population. J. Med. Virol. 3 (59 ), 297 – 302 (1999).
   Google Scholar
• Fernández-Barredo S, Galiana C, García A, Vega S, Gómez MT, Pérez-Gracia MT. Detection of hepatitis E virus shedding in feces of pigs at different stages of production using reverse transcription-polymerase chain reaction. J. Vet. Diagn. Invest. 5 (18 ), 462 – 465 (2006).
   Google Scholar
• Banks M, Bendall R, Grierson S, Heath G, Mitchell J, Dalton H. Human and porcine hepatitis E virus strains, United Kingdom. Emerg. Infect. Dis. 5 (10 ), 953 – 955 (2004).
   Google Scholar
• Huang FF, Haqshenas G, Guenette DK et al. Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J. Clin. Microbiol. 4 (40 ), 1326 – 1332 (2002).
   Google Scholar
• He J, Innis BL, Shrestha MP et al. Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal. J. Clin. Microbiol. 12 (40 ), 4493 – 4498 (2002).
   Google Scholar
• Meng XJ, Purcell RH, Halbur PG et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl Acad. Sci. USA 18 (94 ), 9860 – 9865 (1997).
   Google Scholar
• Pérez-Gracia MT, García M, Suay B, Mateos-Lindemann ML. Current knowledge on Hepatitis E. J. Clin. Transl Hepatol. 3 (2 ), 117 – 126 (2015).
   PubMedGoogle Scholar
• Li TC, Yamakawa Y, Suzuki K et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71, 7207 – 7213 (1997).
   PubMed Web of Science ®Google Scholar
• Tam AW, Smith MM, Guerra ME et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185, 120 – 131 (1991).
   PubMed Web of Science ®Google Scholar
• Parvez MK, Al-Dosari MS. Evidence of MAPK-JNK1/2 activation by hepatitis E virus ORF3 protein in cultured hepatoma cells. Cytotechnology 67 (3 ), 545 – 550 (2015).
   PubMed Web of Science ®Google Scholar
• Khudyakov YE, Favorov MO, Khudyakova NS et al. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J. Virol. 68, 7067 – 7074 (1994).
   PubMed Web of Science ®Google Scholar
• Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J. Med. Virol. 2 (65 ), 282 – 292 (2001).
   Google Scholar
• Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 16, 5 – 36 (2006).
   PubMed Web of Science ®Google Scholar
• Smith DB, Simmonds P, International Committee on Taxonomy of Viruses Hepeviridae Study Group et al. Consensus proposals for classification of the family Hepeviridae. J. Gen. Virol. 95 (Pt 10 ), 2223 – 2232 (2014).
   PubMed Web of Science ®Google Scholar
• Smith DB, Purdy MA, Simmonds P. Genetic variability and the classification of hepatitis E virus. J. Virol. 87 (8 ), 4161 – 4169 (2013).
   PubMed Web of Science ®Google Scholar
• Woo PC, Lau SK, Teng JL et al. New hepatitis E virus genotype in camels, the Middle East. Emerg. Infect. Dis. 20 (6 ), 1044 – 1048 (2014).
   PubMed Web of Science ®Google Scholar
• Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect. Genet. Evol. 22, 40 – 59 (2014).
   PubMed Web of Science ®Google Scholar
• Guan D, Li W, Su J. Asian musk shrew as a reservoir of rat hepatitis E virus, China. Emerg. Infect. Dis. 19 (8 ), 1341 – 1343 (2013).
   PubMed Web of Science ®Google Scholar
• Batts W, Yun S, Hedrick R, Winton J. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res. 158, 116 – 123 (2011).
   PubMed Web of Science ®Google Scholar
• Takahashi M, Tanaka T, Takahashi H et al. Hepatitis E virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J. Clin. Microbiol. 48, 1112 – 1125 (2010).
   PubMed Web of Science ®Google Scholar
• Tanaka T, Takahashi M, Kusano E, Okamoto H. Development and evaluation of an efficient cell-culture system for Hepatitis E virus. J. Gen. Virol. 88, 903 – 911 (2007).
   PubMed Web of Science ®Google Scholar
• Tanaka T, Takahashi M, Takahashi H et al. Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J. Clin. Microbiol. 47, 1906 – 1910 (2009).
   PubMed Web of Science ®Google Scholar
• Williams TP, Kasorndorkbua C, Halbur PG et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J. Clin. Microbiol. 39, 3040 – 3046 (2001).
   PubMed Web of Science ®Google Scholar
• Shukla P, H.T Nguyen, K Faulk et al. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J. Virol. 86, 5697 – 5707 (2012).
   PubMed Web of Science ®Google Scholar
• Rogee S, Talbot N, Caperna T et al. New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J. Gen. Virol. 94, 549 – 558 (2013).
   PubMed Web of Science ®Google Scholar
• Oshiro Y, Yasue H, Takahashi K et al. Mode of swine hepatitis E virus infection and replication in primary human hepatocytes. J. Gen. Virol. 95, 2677 – 2682 (2014).
   PubMed Web of Science ®Google Scholar
• Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, Purcell RH. Release of Genotype 1 hepatitis E Virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J. Virol. 84 (18 ), 9059 – 9069 (2010).
   PubMed Web of Science ®Google Scholar
• Okamoto H. Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood. Rev. Med. Virol. 21, 18 – 31 (2011).
   PubMed Web of Science ®Google Scholar
• Shukla P, Nguyen HT, Torian U et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc. Natl Acad. Sci. USA 108, 2438 – 2443 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang HY, Chen DS, Wu YQ et al. Both swine and human cells are capable to support the replication of swine hepatitis E virus type 4 in vitro. Virus Res. 158, 289 – 293 (2011).
   PubMed Web of Science ®Google Scholar
• Ahmad I, Holla RP, Jameel S. Molecular virology of hepatitis E virus. Virus Res. 161, 47 – 58 (2011).
   PubMed Web of Science ®Google Scholar
• Shiota T, Li TC, Yoshizaki S et al. The hepatitis E virus capsid C-terminal region is essential for the viral life cycle: implication for viral genome encapsidation and particle stabilization. J. Virol. 87, 6031 – 6036 (2013).
   PubMed Web of Science ®Google Scholar
• Kalia M, Chandra V, Rahman SA, Sehgal D, Jameel S. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J. Virol. 83, 12714 – 12724 (2009).
   PubMed Web of Science ®Google Scholar
• Holla P, Ahmad I, Ahmed Z, Jameel S. Hepatitis e virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway. Traffic 16, 398 – 416 (2015).
   PubMed Web of Science ®Google Scholar
• Helenius A. Virus entry: what has pH got to do with it? Nat. Cell Biol. 15, 125 (2013).
   PubMed Web of Science ®Google Scholar
• Yamauchi Y, Helenius A. Virus entry at a glance. J. Cell Sci. 126, 1289 – 1295 (2013).
   PubMed Web of Science ®Google Scholar
• Yu H, Li S, Yang C, Wei M et al. Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78. J. Mol. Model. 17, 987 – 995 (2011).
   PubMed Web of Science ®Google Scholar
• Zheng ZZ, Miao J, Zhao M et al. Role of heat-shock protein 90 in hepatitis E virus capsid trafficking. J. Gen. Virol. 91, 1728 – 1736 (2010).
   PubMed Web of Science ®Google Scholar
• Perttila J, Spuul P, Ahola T. Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1. J. Gen. Virol. 94, 807 – 816 (2013).
   PubMed Web of Science ®Google Scholar
• Agrawal S, Gupta D, Panda SK. The 3′ end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp). Virology 282, 87 – 101 (2001).
   PubMed Web of Science ®Google Scholar
• Graff J, Nguyen H, Kasorndorkbua C et al. In vitro and in vivo mutational analysis of the 3′-terminal regions of hepatitis E virus genomes and replicons. J. Virol. 79, 1017 – 1026 (2005).
   PubMed Web of Science ®Google Scholar
• Parvez MK. The hepatitis E virus ORF1 'X-domain' residues form a putative macrodomain protein/Appr-1′′-pase catalytic-site, critical for viral RNA replication. Gene 566 (1 ), 47 – 53 (2015).
   PubMed Web of Science ®Google Scholar
• Emerson SU, Nguyen HT, Torian U et al. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J. Virol. 84, 9059 – 9069 (2010).
   PubMed Web of Science ®Google Scholar
• Nagashima S, Takahashi M, Jirintai et al. A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J. Gen. Virol. 92, 269 – 278 (2011).
   PubMed Web of Science ®Google Scholar
• Surjit M, Oberoi R, Kumar R, Lal SK. Enhanced alpha1 microglobulin secretion from hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101. J. Biol. Chem. 281, 8135 – 8142 (2006).
   PubMed Web of Science ®Google Scholar
• Jia Z, Yi Y, Liu J et al. Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005–2006. PLoS ONE 9 (10 ), e110837 (2014).
   Web of Science ®Google Scholar
• Kamar N, Bendall R, Legrand-Abravanel F et al. Hepatitis E. Lancet 379, 2477 – 2488 (2012).
   PubMed Web of Science ®Google Scholar
• Kumar S, Subhadra S, Singh B, Panda BK. Hepatitis E: the current scenario. Int. J. Infect. Dis. 17 (4 ), e228 – e233 (2013).
   PubMed Web of Science ®Google Scholar
• Kmush B, Wierzba T, Krain L, Nelson K, Labrique AB. Epidemiology of hepatitis E in low- and middle-income countries of Asia and Africa. Semin. Liver Dis. 33, 15 – 29 (2013).
   PubMed Web of Science ®Google Scholar
• CIWEC Clinic Travel Medicine Center. www.ciwec-clinic.com
   Google Scholar
• Kim JH, Nelson KE, Panzner U et al. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis. 14, 308 (2014).
   PubMed Web of Science ®Google Scholar
• Aggarwal R. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review. WHO, Geneva, Switzerland (2010).
   Google Scholar
• Browne LB, Menkir Z, Kahi V et al. Notes from the field: hepatitis E outbreak among refugees from South Sudan – Gambella, Ethiopia, April 2014–January 2015. MMRW Morb Mortal Wkly Rep. 64 (19 ), 537 (2015).
   PubMed Web of Science ®Google Scholar
• Ahmed JA, Moturi E, Spiegel P et al. Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg. Infect. Dis. 19 (6 ), 1010 – 1012 (2013).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Investigation of hepatitis E outbreak among refugees – Upper Nile, South Sudan, 2012–2013. MMRW Morb Mortal Wkly Rep. 62 (29 ), 581 – 586 (2013).
   PubMed Web of Science ®Google Scholar
• Teshale EH, Grytdal SP, Howard C et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin. Infect. Dis. 50 (7 ), 1006 – 1010 (2010).
   PubMed Web of Science ®Google Scholar
• Villarejos VM, Provost PJ, Ittensohn OL, McLean AA, Hilleman MR. Seroepidemiologic investigation of human hepatitis caused by A, B and a possible third virus. Proc. Soc. Exp. Biol. Med. 152 (4 ), 524 – 528 (1976).
   PubMed Web of Science ®Google Scholar
• Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 26 (Suppl. 3 ), 135 – 138 (1991).
   PubMedGoogle Scholar
• Arankalle VA, Chadha MS, Tsarev SA et al. Seroepidemiology of water-borne hepatitis in India and evidence of third enterically-transmitted hepatitis agent. Proc. Natl Acad. Sci. USA 91 (8 ), 3428 – 3432 (1994).
   PubMed Web of Science ®Google Scholar
• Hepatitis D, E and GB-C: Global Status. Gideon e-books. (2016). www.gideononline.com/ebooks/disease/hepatitis-d-e-and-g-global-status
   Google Scholar
• Corwin AL, Khiem HB, Clayson ET et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am. J. Trop. Med. Hyg. 54 (6 ), 559 – 562 (1996).
   PubMed Web of Science ®Google Scholar
• Dawson GJ, Mushahwar IK, Chau KH, Gitnick GL. Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet 240, 426 – 427 (1992).
   Google Scholar
• Chapman BA, Burt MJ, Wilkinson ID, Schousboe MI. Community acquired viral hepatitis in New Zealand: a case of sporadic hepatitis E virus infection. Aust. NZ J. Med. 23, 722 – 723 (1993).
   PubMedGoogle Scholar
• Fletcher J. A traveller returning from Nepal with hepatitis E. Med. J. Aust. 159, 563 (1993).
   PubMed Web of Science ®Google Scholar
• Acharya SK, Panda SK. Hepatitis E: water, water everywhere – now a global disease. J. Hepatol. 54, 9 – 11 (2011).
   PubMed Web of Science ®Google Scholar
• García M, Fernández-Barredo S, Pérez-Gracia MT. Detection of hepatitis E virus (HEV) through the different stages of pig manure composting plants. Microb. Biotechnol. 7 (1 ), 26 – 31 (2013).
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 356, 1081 – 1082 (2000).
   PubMed Web of Science ®Google Scholar
• Khuroo MS, Kamili S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J. Viral Hepat. 16, 519 – 523 (2009).
   PubMed Web of Science ®Google Scholar
• Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Tomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur. J. Obstet. Gynecol. Reprod. Biol. 100, 9 – 15 (2001).
   PubMed Web of Science ®Google Scholar
• Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 345, 1025 – 1026 (1995).
   PubMed Web of Science ®Google Scholar
• Psichogiou M, Tzala E, Boletis J et al. Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scand. J. Infect. Dis. 28, 443 – 445 (1996).
   PubMed Web of Science ®Google Scholar
• Galiana C, Fernández-Barredo S, Pérez-Gracia MT. Prevalence of hepatitis E virus (HEV) and risk factors in pig workers and blood donors. Enferm. Infecc. Microbiol. Clin. 28, 602 – 607 (2010).
   PubMed Web of Science ®Google Scholar
• Mansuy JM, Bendall R, Legrand-Abravanel F et al. Hepatitis E virus antibodies in blood donors, France. Emerg. Infect. Dis. 17, 2309 – 2323 (2011).
   PubMed Web of Science ®Google Scholar
• Wichmann O, Schimanski S, Koch J et al. Phylogenetic and case–control study on hepatitis E virus infection in Germany. J. Infect. Dis. 198, 1732 – 1741 (2008).
   PubMedGoogle Scholar
• Said B, Ijaz S, Kafatos G et al. Hepatitis E outbreak on cruise ship. Emerg. Infect. Dis. 15, 1738 – 1744 (2009).
   PubMed Web of Science ®Google Scholar
• Echevarría JM. Light and darkness: prevalence of hepatitis E virus infection among the general population. Scientifica (Cairo) 2014, 481016 (2014).
   PubMedGoogle Scholar
• Matsubayashi K, Nagaoka Y, Sakata H et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 44 (6 ), 934 – 940 (2004).
   PubMed Web of Science ®Google Scholar
• Boxall E, Herborn A, Kochethu G et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus. Med. 16 (2 ), 79 – 83 (2006).
   PubMed Web of Science ®Google Scholar
• Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg. Infect. Dis. 13 (4 ), 648 – 649 (2007).
   PubMed Web of Science ®Google Scholar
• Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J. Transmission, diagnosis and management of hepatitis E: an update. Hepat. Med. 6, 45 – 59 (2014).
   PubMedGoogle Scholar
• Mateos-Lindemann ML, Diez-Aguilar M, González-Galdamez A, Graus-Morales J, Moreno-Zamora A, Pérez-Gracia MT. Acute, chronic and fulminant hepatitis E: seven years of experience (2004–2011). Enferm. Infecc. Microbiol. Clin. 31, 595 – 598 (2013).
   PubMed Web of Science ®Google Scholar
• Mateos-Lindemann ML, Diez-Aguilar M, González-Galdámez A et al. Acute, chronic and fulminant hepatitis E: ten years of experience (2004–2013). Int. J. Gastroenterol. Dis. Ther. 1, 102 – 105 (2014).
   Google Scholar
• Labrique AB, Kuniholm MH, Nelson K. The global impact of hepatitis E: new horizons for an emerging virus. In : Emerging Infections (9th Edition). Scheld WM, Grayson ML, Hughes JM( Eds ) . ASM Press, VA, USA, 53 – 92 (2010).
   Google Scholar
• Aggarwal R. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. Semin. Liver Dis. 33, 30 – 40 (2013).
   PubMed Web of Science ®Google Scholar
• Dalton HR, Bendall RP, Rashid M et al. Host risk factors and autochthonous hepatitis E infection. Eur. J. Gastroenterol. Hepatol. 23, 1200 – 1205 (2011).
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 28, 1190 – 1199 (2008).
   PubMed Web of Science ®Google Scholar
• Davern TJ, Chalasami N, Fontana RJ et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 41, 1665 – 1672 (2011).
   Google Scholar
• Peron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J. Hepatol. 54, 1323 – 1324, author reply 1324 – 1325 (2011).
   PubMed Web of Science ®Google Scholar
• Kamar N, Rostaing L, Legrand-Abravanet F, Izopet J. How should hepatitis E virus infection be defined in organ-transplant recipients? Am. J. Transplant. 13, 1935 – 1936 (2013).
   PubMed Web of Science ®Google Scholar
• Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin. Res. Hepatol. Gastroenterol. 39, 20 – 27 (2015).
   PubMed Web of Science ®Google Scholar
• González-Tallón AI, Moreira Vicente V, Mateos Lindemann ML. Hepatitis crónica E en paciente immunocompetente. Gastroenterol. Hepatol. 34, 398 – 400 (2011).
   PubMedGoogle Scholar
• Grewal P, Kamili S, Motamed D. Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology 59, 347 – 348 (2013).
   PubMedGoogle Scholar
• Junge N, Pischke S, Baumann U et al. Results of single-center liver transplantation and report on successful treatment with ribavirin. Pediatr. Transplant. 17, 343 – 347 (2013).
   PubMed Web of Science ®Google Scholar
• Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy. Semin. Liver Dis. 33, 62 – 70 (2013).
   PubMed Web of Science ®Google Scholar
• Geng Y, Zhang H, Huang W, Geng K, Li Z. Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukaemia. Hepat. Mon. 14, e15618 (2014).
   PubMed Web of Science ®Google Scholar
• Kamar N, Selves J, Mansuy JM et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 358, 811 – 817 (2008).
   PubMed Web of Science ®Google Scholar
• Kamar N, Izopet J, Cintas P et al. Hepatitis E virus induced-neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am. J. Transplant. 10, 1321 – 1324 (2010).
   PubMed Web of Science ®Google Scholar
• Kamar N, Abravanel F, Selves J et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis E virus infection after organ transplantation. Transplantation 89, 353 – 360 (2010).
   PubMed Web of Science ®Google Scholar
• Halac U, Beland K, Lapierre P et al. Chronic hepatitis E infection in children with liver transplantation. Gut 61, 597 – 603 (2010).
   Web of Science ®Google Scholar
• Versluis J, Pas SD, Agteresch HJ et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 122, 1079 – 1086 (2013).
   PubMed Web of Science ®Google Scholar
• le Coutre P, Meisel H, Hofmann J et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut. 58, 699 – 702 (2009).
   PubMed Web of Science ®Google Scholar
• Haagsma E, van den Berg AP, Porte R et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 14, 547 – 553 (2008).
   PubMed Web of Science ®Google Scholar
• Schlosser B, Stein A, Neuhaus R et al. Transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J. Hepatol. 56, 500 – 502 (2012).
   PubMed Web of Science ®Google Scholar
• Hewitt EP, Ijaz S, Brailsford SR et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384, 1766 – 1773 (2014).
   PubMed Web of Science ®Google Scholar
• Dalton HR, Bendall RP, Keane FE, Tender RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N. Engl. J. Med. 361, 1025 – 1027 (2009).
   PubMed Web of Science ®Google Scholar
• Kenfak-Foguena A, Schoni-Affolter F, Bürgisser P et al. Hepatitis E seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg. Infect. Dis. 17, 1074 – 1078 (2011).
   PubMed Web of Science ®Google Scholar
• Mateos Lindemann ML, Diez-Aguilar M, Gonzalez Galdamez AL et al. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J. Med. Virol. 86, 71 – 74 (2014).
   PubMedGoogle Scholar
• Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N. Engl. J. Med. 361, 1025 – 1027 (2009).
   PubMed Web of Science ®Google Scholar
• Mateos-Lindemann ML, Gonzalez-Galdámez A, Bordallo-Cardona M, Pérez-Gracia MT. Are HIV-infected patients a high-risk population for hepatitis E virus infection in Spain? Enferm. Infecc. Microbiol. Clin. 30, 582 – 583 (2012).
   PubMed Web of Science ®Google Scholar
• Jardi R, Crespo M, Homs M et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med. 86, 71 – 74 (2012).
   Google Scholar
• Dalton HR, Bendall RP, Rashid M et al. Host risk factors and autochthonous hepatitis E infection. Eur. J. Gastroenterol. Hepatol. 23, 1200 – 1205 (2011).
   PubMed Web of Science ®Google Scholar
• Kumar Acharya S, Kumar Sharma P, Singh R et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J. Hepatol. 46, 387 – 394 (2007).
   PubMed Web of Science ®Google Scholar
• Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect. Dis. 8, 698 – 709 (2008).
   PubMed Web of Science ®Google Scholar
• Kamar N, Bendall RP, Peron JM et al. Hepatitis E virus and neurologic disorders. Emerg. Infect. Dis. 17, 173 – 179 (2011).
   PubMed Web of Science ®Google Scholar
• Van der Berg, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Guillen AP. Guillain–Barre syndrome associated with preceding hepatitis E virus infection. Neurology 82, 491 – 497 (2014).
   PubMed Web of Science ®Google Scholar
• Thapa R, Biswas B, Mallick D, Ghosh A. Acute pancreatitis complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clin. Pediatr. (Phila) 48, 199 – 201 (2009).
   PubMed Web of Science ®Google Scholar
• Singh NK, Gangappa M. Acute immune thrombocytopenia associated with hepatitis E in an adult. Am. J. Hematol. 82, 942 – 943 (2007).
   PubMed Web of Science ®Google Scholar
• Thapa R, Mallick D, Biswas B. Henoch Schonlein purpura triggered by acute hepatitis E virus infection. J. Emerg. Med. 39, 218 – 219 (2010).
   PubMed Web of Science ®Google Scholar
• Kamar N, Weclawiack H, Guilbeaud-Frugier C et al. Hepatitis E virus and the kidney in solid-organ-transplant patient. Transplantation 93, 617 – 623 (2012).
   PubMed Web of Science ®Google Scholar
• Dalton HR, Hunter JG, Bendall R. Autochthonous hepatitis E in developed countries and HEV/HIV coinfection. Semin. Liver. Dis. 33, 50 – 61 (2013).
   PubMed Web of Science ®Google Scholar
• Dawson GJ, Mushahwar IK, Chau KH, Gitnick GL. Detection of long-lasing antibody to hepatitis E virus in a US traveller to Pakistan. Lancet 340, 426 – 427 (1992).
   PubMed Web of Science ®Google Scholar
• Hyams C, Mabayoje DA, Copping R et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J. Med. Virol. 86, 478 – 483 (2014).
   PubMed Web of Science ®Google Scholar
• Herremans M, Bakker J, Duizer E, Vennema H, Koopsmans MO. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin. Vaccine Immunol. 14, 562 – 568 (2007).
   PubMed Web of Science ®Google Scholar
• Kamar N, Izopet J, Tripon S et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N. Engl. J. Med. 370, 1111 – 1120 (2014).
   PubMed Web of Science ®Google Scholar
• Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HGM. Treatment of chronic hepatitis E in liver transplant recipients with pegilated interferon alpha-2b. Liver Transpl. 16, 474 – 477 (2010).
   PubMed Web of Science ®Google Scholar
• Legrand-Abravanel F, Kamar N, Sandres-Saune K et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J. Infect. Dis. 202, 835 – 844 (2010).
   PubMed Web of Science ®Google Scholar
• Bihl F, Negro F. Chronic hepatitis E in the immunosuppressed: a new source of trouble? J. Hepatol. 50, 435 – 437 (2009).
   PubMedGoogle Scholar
• Kamar N, Rostaing L, Abravanel F et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 139, 1612 – 1618 (2010).
   PubMed Web of Science ®Google Scholar
• Mallet V, Nicand E, Sultanik P. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann. Intern. Med. 153 (2 ), 85 – 89 (2010).
   PubMed Web of Science ®Google Scholar
• Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J. Heart Lung Transplant. 30 (7 ), 841 – 843 (2011).
   PubMed Web of Science ®Google Scholar
• Pischke S, Stiefel P, Franz B et al. Chronic hepatitis E in heart transplant recipients. Am. J. Transplant. 12 (11 ), 3128 – 3133 (2012).
   PubMed Web of Science ®Google Scholar
• de Niet A, Zaaijer HL, ten Berge I, Weegink CJ, Reesink HW, Beuers U. Chronic hepatitis E after solid organ transplantation. Neth. J. Med. 70 (6 ), 261 – 266 (2012).
   PubMed Web of Science ®Google Scholar
• Del Bello A, Arné-Bes MC, Lavayssière L, Kamar N. Hepatitis E virus-induced severe myositis. J. Hepatol. 57 (5 ), 1152 – 1153 (2012).
   PubMed Web of Science ®Google Scholar
• Pischke S, Hardtke S, Bode U et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int. 33 (5 ), 722 – 726 (2013).
   PubMed Web of Science ®Google Scholar
• Pischke S, Greer M, Hardtke S et al. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transpl. Infect. Dis. 16 (2 ), 333 – 339 (2014).
   PubMed Web of Science ®Google Scholar
• Galante A, Pischke S, Polywka S et al. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting. Transpl. Infect. Dis. 17 (4 ), 617 – 622 (2015).
   PubMed Web of Science ®Google Scholar
• Antón MD, Cuchillo H, Ferrando I et al. Treatment with ribavirin of hepatitis E virus chronic infection in transplanted patients. Rev. Esp. Enferm. Dig. 107 (3 ), 187 – 188 (2015).
   PubMed Web of Science ®Google Scholar
• Klein F, Neuhaus R, Hofmann J, Rudolph B, Neuhaus P, Bahra M. Successful treatment of chronic hepatitis E after an orthotopic liver transplant with ribavirin monotherapy. Exp. Clin. Transplant. 13 (3 ), 283 – 286 (2015).
   PubMed Web of Science ®Google Scholar
• Kamar N, Rostaing L, Abravanel F et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin. Infect. Dis. 50 (5 ), e30 – e33 (2010).
   PubMed Web of Science ®Google Scholar
• Kamar N, Abravanel F, Garrouste C et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol. Dial. Traspl. 25, 2792 – 2795 (2010).
   PubMed Web of Science ®Google Scholar
• Arankalle VA, Chadha MS, Dama BM, Tsarev SA, Purcell RH, Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J. Viral Hepat. 3, 199 – 204 (1998).
   Google Scholar
• Purcell RH, Nguyen H, Shapiro M et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 21, 2607 – 2615 (2003).
   PubMed Web of Science ®Google Scholar
• Kamili S, Spelbring J, Carson D, Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J. Infect. Dis. 189, 258 – 264 (2004).
   PubMed Web of Science ®Google Scholar
• Shrestha MP, Scott RM, Joshi DM et al. Safety and efficacy of a recombinant hepatitis E vaccine. N. Engl. J. Med. 356, 895 – 903 (2007).
   PubMed Web of Science ®Google Scholar
• Li SW, Zhang J, Li YM et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23, 2893 – 2901 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu CB, Li RC et al. Randomized-controlled Phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 27, 1869 – 1874 (2009).
   PubMed Web of Science ®Google Scholar
• Zhu FC, Zhang J, Zhang XF et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomized, double-blind placebo-controlled, Phase 3 trial. Lancet 376, 895 – 902 (2010).
   PubMed Web of Science ®Google Scholar
• Harmanci H, Duclos P, Rodriguez Hernandez CA et al. WHO approaches to evaluating the potential use and quality of hepatitis E vaccine. Open Forum Infect. Dis. 1 (3 ), ofu099 (2014).
   PubMedGoogle Scholar
• WHO. Hepatitis E vaccine: WHO position paper, May 2015. Wkly Epidemiol Rec. 18, 185 – 200 (2015).
   Google Scholar
• Liu P, Du RJ, Wang L et al. Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine. PLoS ONE 9 (1 ), e87600 (2014).
   Web of Science ®Google Scholar
• Wang L, Cao D, Wei C et al. A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine 32, 445 – 452 (2014).
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou X, Debing Y et al. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatiits E virus. Gastroenterology 146, 1775 – 1783 (2014).
   PubMed Web of Science ®Google Scholar
• Zhou X, Wang Y, Metselaar HJ et al. Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of P13K–PKB–mTOR pathway. J. Hepatol. 61, 746 – 754 (2014).
   PubMed Web of Science ®Google Scholar